Sign in

CIK 0001650664

  • Non-accelerated filer
  • Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464097528
Phone
+1 617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
  1. 4 Open-market sale 10% owner sold 30,830 shares at $16.30 ($502,529)
  2. 4 Open-market sale Director sold 30,830 shares at $16.30 ($502,529)
  3. 4 Open-market sale 10% owner sold 88,900 shares at an average $16.96 ($1,507,309)
  4. 4 Open-market sale Director sold 88,900 shares at an average $16.96 ($1,507,309)
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market sale Director sold 500,000 shares at $16.80 ($8,400,000)
  9. 4 Open-market sale 10% owner sold 500,000 shares at $16.80 ($8,400,000)
  10. 4 Open-market sale 10% owner sold 5,890 shares at $15.90 ($93,666)
  11. 4 Open-market sale Chief Operating Officer sold 1,000 shares at $20.00 ($20,000)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Other disposition 10% owner disposed of 750,000 shares (other)
  14. 4 Other acquisition Director acquired 1,485 shares (other)
  15. 4 Other disposition 10% owner disposed of 1,550,271 shares (other)
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 4 Conversion 10% owner acquired 2,649,572 shares (conversion)
  19. 4 Conversion 10% owner acquired 4,955,316 shares (conversion)
  20. 4 Conversion Director acquired 4,656,173 shares (conversion)

Page 16 of 18 · 351 filings